Amgen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment.
AMGN Key Statistics
AMGN News
Amgen ( ) Full Year 2024 Results Key Financial Results Revenue: US$33.4b (up 19% from FY 2023). Net income: US$4.09b (down 39% from FY 2023). Profit margin:...
Amgen Inc ((AMGN)) has held its Q4 earnings call. Read on for the main highlights of the call. Maximize Your Portfolio with Data Driven Insights: Leverage the...
Erste Group analyst Hans Engel upgraded Amgen (AMGN) to Buy from Hold. Amgen has a higher operating margin and a higher return on equity than the sector average...
Analyst ratings
47%
of 34 ratingsMore AMGN News
On Tuesday, Amgen Inc AMGN reported fourth-quarter sales of $9.10 billion, up 11% year-over-year, beating the consensus of $8.9 billion. Product sales grew 11%...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen (AMGN) to $328 from $322 and keeps an Equal Weight rating on the shares. Amgen post...
Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter of Fiscal Year 2024. Earnings per sh...
Amgen (AMGN) provided updates on selected product and pipeline programs, including that a Phase 1 study of AMG 513 in people living with obesity was placed on c...
Biopharmaceutical company Amgen (NASDAQ:AMGN) is set to announce its fourth quarter earnings results on Tuesday, February 4th, after the closing bell. Wall Stre...
Amgen Inc. ( ) has announced that it will be increasing its dividend from last year's comparable payment on the 7th of March to $2.38. Based on this payment, th...